Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumors

Endocrine-Related Cancer

Volumn 18, Issue 6, 2011, Pages

  Ahmed, Deeqa ^a,b   Lothe, Ragnhild A ^a,b   Rivedal, Edgar ^a,b   Lind, Guro E ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN GAMMA 1; UNCLASSIFIED DRUG;

CANCER LOCALIZATION; CLINICAL FEATURE; COHORT ANALYSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA METHYLATION; GENE MUTATION; HUMAN; NOTE; PROMOTER REGION; QUANTITATIVE STUDY; VALIDATION STUDY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; CONNEXINS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; ROC CURVE; YOUNG ADULT;

EID: 84855943692     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0204     Document Type: Note

References (12)

1. Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH & Hoff G 2002 Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP Study (Norwegian Colorectal Cancer Prevention). Scandinavian Journal of Gastroenterology 37 568-573. (doi:10.1080/ 00365520252903125)
2. Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, Kallioniemi A, Meling GI, Skotheim RI, Rognum TO et al. 2008 Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. Journal of Translational Medicine 6 13. (doi:10.1186/1479-5876-6-13)
3. Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G et al. 2011a Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Molecular Cancer 10 85. (doi:10.1186/1476-4598-10-85)
4. Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, Nesbakken A, Stenmark H & Lothe RA 2011b SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene 30 3967-3978. (doi:10.1038/onc.2011.109)
5. Meling GI, Lothe RA, Børresen AL, Hauge S, Graue C, Clausen OP & Rognum TO 1991 Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. British Journal of Cancer 64 475-480. (doi:10.1038/bjc.1991.334)
6. Mori Y, Olaru AV, Cheng Y, Agarwal R, Yang J, Luvsanjav D, Yu W, Selaru FM, Hutfless S, Lazarev M et al. 2011 Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine-Related Cancer 18 465-478. (doi:10.1530/ERC-11-0083)
7. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL & Fuchs CS 2009 CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58 90-96. (doi:10.1136/gut.2008.155473)
8. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K et al. 2007 Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. PNAS 104 18654-18659. (doi:10.1073/pnas.0704652104)
9. Sirnes S, Honne H, Ahmed D, Danielsen SA, Rognum TO, Meling GI, Leithe E, Rivedal E, Lothe RA & Lind GE 2011 DNA methylation analyses of the connexin gene family reveal silencing of GJC1 (connexin45) by promoter hypermethylation in colorectal cancer. Epigenetics 6 602-609. (doi:10.4161/epi.6.5.15237)
10. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM & Vatn MH 1999 Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scandinavian Journal of Gastroenterology 34 414-420. (doi:10.1080/003655299750026443)
11. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB & Issa JP 1999 CpG island methylator phenotype in colorectal cancer. PNAS 96 8681-8686. (doi:10.1073/pnas.96.15.8681)
12. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D et al. 2006 CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics 38 787-793. (doi:10.1038/ng1834)